CRISPR Reagents

AGTR1 Gene Knockout Kit (Human)

Knockout any human or mouse protein-coding gene with XDel technology.

Bulk Upload
Need a quote? Add to cart and download one instantly at checkout — to reference on a purchase order, submit for budget approval, or keep for your records. No need to contact sales.

ENSG00000144891
Angiotensin II is a potent vasopressor hormone and a primary regulator of aldosterone secretion. It is an important effector controlling blood pressure and volume in the cardiovascular system. It acts through at least two types of receptors. This gene encodes the type 1 receptor which is thought to mediate the major cardiovascular effects of angiotensin II. This gene may play a role in the generation of reperfusion arrhythmias following restoration of blood flow to ischemic or infarcted myocardium. It was previously thought that a related gene, denoted as AGTR1B, existed; however, it is now believed that there is only one type 1 receptor gene in humans. Alternative splicing of this gene results in multiple transcript variants. [provided by RefSeq, Aug 2020]
Molecular Function6
Biological Process27
Cellular Component2

Common questions about the AGTR1 knockout kit

How many guides does the AGTR1 knockout kit use?
The kit's XDel design targets AGTR1 with 3 guides, and the earliest cut is in exon 3 of its canonical transcript.
Which AGTR1 transcripts does the knockout cut?
The XDel guides cut 28 AGTR1 transcripts, including the canonical transcript ENST00000349243. They cut all 28 of its CCDS protein-coding transcripts.
Do the AGTR1 guides cut other genes?
No. Our design analysis predicts no off-target potential in any other gene for these guides.
Gene Knockout Kits Provide Superior Editing Efficiency in iPSC, Immortalized, and Primary Cells and Consistent Protein Depletion Using the XDel Design
XDel is a cutting-edge CRISPR knockout technology designed to remove the guesswork from gene editing. By leveraging an innovative guide RNA design strategy, XDel delivers highly efficient, consistent, and reproducible gene knockouts—empowering researchers to accelerate their discoveries with confidence.